Radicut Oral Form Now Available for ALS Patients in Japan: Mitsubishi Tanabe

Mitsubishi Tanabe Pharma launched an oral suspension version of the ALS drug Radicut (edaravone) in Japan on April 17, a line extension from its currently available IV infusion form. The oral product joined the NHI price list on March 15...read more